"Mutation burden" trang 1 - tải miễn phí từ tailieuXANH
NIMBus: A negative binomial regression based integrative method for mutation burden analysis

NIMBus: A negative binomial regression based integrative method for mutation burden analysis
25    53    0
Impact of JAK2V617F mutation burden on disease phenotype in Chinese patients with JAK2V617F-positive Polycythemia vera (PV) and Essential thrombocythemia (ET)

Impact of JAK2V617F mutation burden on disease phenotype in Chinese patients with JAK2V617F-positive Polycythemia vera (PV) and Essential thrombocythemia (ET)
7    42    0
A next-generation sequencing-based strategy combining microsatellite instability and tumor mutation burden for comprehensive molecular diagnosis of advanced colorectal cancer

A next-generation sequencing-based strategy combining microsatellite instability and tumor mutation burden for comprehensive molecular diagnosis of advanced colorectal cancer
12    45    1
Gene expression and immune infiltration in melanoma patients with different mutation burden

Gene expression and immune infiltration in melanoma patients with different mutation burden
12    41    1
Identification of NTRK3 as a potential prognostic biomarker associated with tumor mutation burden and immune infiltration in bladder cancer

Identification of NTRK3 as a potential prognostic biomarker associated with tumor mutation burden and immune infiltration in bladder cancer
13    41    1
Radiomic assessment as a method for predicting tumor mutation burden (TMB) of bladder cancer patients: A feasibility study

Radiomic assessment as a method for predicting tumor mutation burden (TMB) of bladder cancer patients: A feasibility study
9    68    1
The relationship between blood-based tumor mutation burden level and efficacy of PD-1/PD-L1 inhibitors in advanced nonsmall cell lung cancer: A systematic review and meta-analysis

The relationship between blood-based tumor mutation burden level and efficacy of PD-1/PD-L1 inhibitors in advanced nonsmall cell lung cancer: A systematic review and meta-analysis
17    238    1
Comparison of tumor mutation burden of 300 various non-Hodgkin lymphomas using panel based massively parallel sequencing

Comparison of tumor mutation burden of 300 various non-Hodgkin lymphomas using panel based massively parallel sequencing
11    262    1
Repeat-induced point mutation in Neurospora crassa causes the highest known mutation rate and mutational burden of any cellular life

Repeat-induced point mutation in Neurospora crassa causes the highest known mutation rate and mutational burden of any cellular life
23    162    1
An immune-centric exploration of BRCA1 and BRCA2 germline mutation related breast and ovarian cancers

An immune-centric exploration of BRCA1 and BRCA2 germline mutation related breast and ovarian cancers
16    58    0
First insight into the somatic mutation burden of neurofibromatosis type 2- associated grade I and grade II meningiomas: A case report comprehensive genomic study of two cranial meningiomas with vastly different clinical presentation

First insight into the somatic mutation burden of neurofibromatosis type 2- associated grade I and grade II meningiomas: A case report comprehensive genomic study of two cranial meningiomas with vastly different clinical presentation
10    72    0
The neoepitope landscape of breast cancer: Implications for immunotherapy

The neoepitope landscape of breast cancer: Implications for immunotherapy
10    59    0
Safety and efficacy of sintilimab combined with oxaliplatin/capecitabine as first-line treatment in patients with locally advanced or metastatic gastric/gastroesophageal junction adenocarcinoma in a phase Ib clinical trial

Safety and efficacy of sintilimab combined with oxaliplatin/capecitabine as first-line treatment in patients with locally advanced or metastatic gastric/gastroesophageal junction adenocarcinoma in a phase Ib clinical trial
8    54    0
Novel γδ T cell-based prognostic signature to estimate risk and aid therapy in hepatocellular carcinoma

Novel γδ T cell-based prognostic signature to estimate risk and aid therapy in hepatocellular carcinoma
19    343    1
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.